Zhang Dandan, Liang Jianping, Lv Yanhua, Huang Xikun, Guo Weihong
Department of Respiratory and Critical Care Medicine, Zhongshan City People's Hospital, China.
Respir Med Case Rep. 2024 Nov 19;52:102140. doi: 10.1016/j.rmcr.2024.102140. eCollection 2024.
Lymphoma originates from the lymphatic hematopoietic system and is prone to develop second tumors. We reported a case of lymphoma initially manifesting systematic lymphadenopathies and lung space-occupying lymphoma that developed to lung squamous cell carcinoma in 30 months. The diseases once responded satisfactorily to chemotherapy combined with immunotherapy but progressed after 8 months. Following afatinib administration achieved sustained remission and the progression-free survival is 11 months. Rarely does lymphoma combine with lung cancer and more rarely does lung cancer develop in the original focus of pulmonary lymphoma; first-line and secondary treatment remained potent in treating the complexity.
淋巴瘤起源于淋巴造血系统,且易于发生第二肿瘤。我们报告了一例最初表现为系统性淋巴结病和肺部占位性淋巴瘤的病例,该病例在30个月内发展为肺鳞状细胞癌。该疾病曾对化疗联合免疫治疗反应良好,但8个月后病情进展。服用阿法替尼后实现了持续缓解,无进展生存期为11个月。淋巴瘤合并肺癌很少见,而肺癌在肺淋巴瘤原发病灶处发生则更为罕见;一线和二线治疗在应对这种复杂性方面仍然有效。